Clinical Trials Browser

Phase 2 × OTHER × saracatinib × Clear all

NCT00752206 2020-01-18

A Placebo-Controlled Study of Saracatinib (AZD0530) in Patients With Recurrent Osteosarcoma Localized to the Lung

Phase 2 Terminated

38 enrolled 10 charts

Recurrence, Osteosarcoma

NCT02085603 2018-04-13

SarCaBon

Phase 2 Completed

Neoplasms